ResearcherActive in the last 2 years

Ashwin Somasundaram

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0000-0003-3167-406X; OpenAlex author ID A5063843417.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 3 (principal investigator on 3)
Grants: 0
Collaborators: 28

Papers, trials and grants by year

2019: 1 trial · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper, 1 trial · 2025: 1 paper, 1 trial

Papers 2

Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreat… Co-author DOI 10.1200/po-25-00332 ↗
Future of Dendritic Cell-Based Approaches in Pancreatic Cancer. First author DOI 10.1200/jco.24.00846 ↗

Trials 3

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel Principal investigator NCT06483555 ↗
Autologous CAR-T Cells Targeting B7-H3 in PDAC Principal investigator NCT06158139 ↗
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer Principal investigator NCT03977233 ↗

Closest collaborators

The 25 strongest of 28 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Jen Jen Yeh · 1 shared paper, 2024
- Paper Future of Dendritic Cell-Based Approaches in Pancreatic Cancer. DOI 10.1200/jco.24.00846 ↗
Harshabad Singh · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Mary Linton B. Peters · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Andrea J. Bullock · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Leah H. Biller · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Andrea Catherine Enzinger · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Hanna Kelly Sanoff · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Robert James Mayer · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Douglas Adam Rubinson · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Srivatsan Raghavan · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Rishi Surana · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Hannah L. Williams · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Kimmie Ng · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Thomas Adam Abrams · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Sarah Slater · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Kirsten L. Bryant · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Andrew James Aguirre · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Matthew B.B. Yurgelun · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Aparna R. Parikh · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Brian Matthew Wolpin · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Brandon M. Huffman · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Channing J. Der · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Joseph Douglas Mancias · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Jonathan Andrew Nowak · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗
Kimberly J. Perez · 1 shared paper, 2025
- Paper Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibit… DOI 10.1200/po-25-00332 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.